Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$16.0M
-37.1% from 2023
Prescriptions
23K
$692.57 per claim
Patients
2,883
2,643 prescribers
Total spending, 2024
$16.0M
$5,560.84 per patient
Medicare prescription drug plans paid $16.0M for Efavirenz-Emtric-Tenofov Disop in 2024, for 23,119 prescriptions and refills to 2,883 patients (down 37.1% from 2023). The average cost per claim was $692.57.
New York had the highest Medicare cost for Efavirenz-Emtric-Tenofov Disop in 2024: $3.2M for 3,239 claims, followed by California ($1.4M).
Jeffrey A Lederman, infectious disease in New Rochelle, NY, had the highest Medicare cost for Efavirenz-Emtric-Tenofov Disop in 2024: 60 claims costing $128K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jeffrey A Lederman New Rochelle, NY | Infectious Disease | 60 | Under 11 | $128K |
| Joseph C Gathe Jr. Houston, TX | Infectious Disease | 147 | 16 | $114K |
| James F Swiencicki Jr. |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 3,166 | 30,857 | 3,608 | $32.2M |
| 2023 | 2,945 | 26,531 | 3,188 | $25.5M |
| 2024 | 2,643 | 23,119 | 2,883 | $16.0M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 61 |
| Under 11 |
| $93K |
| Gary M Cox Durham, NC | Infectious Disease | 86 | Under 11 | $84K |
| Louis M Weiss Bronx, NY | Infectious Disease | 34 | Under 11 | $82K |
| Scott R Rosman Binghamton, NY | Nurse Practitioner | 53 | Under 11 | $69K |
| Simon E Valladares Miami, FL | Physician Assistant | 48 | Under 11 | $68K |
| Penny Jaffe Houston, TX | Infectious Disease | 50 | Under 11 | $64K |
| Dora V Savani-Blackham Edgewood, KY | Infectious Disease | 47 | Under 11 | $64K |
| Bruce M Doxey Austin, TX | Family Practice | 17 | Under 11 | $64K |
| Jonell B Poe Augusta, GA | Physician Assistant | 25 | Under 11 | $61K |
| Michelle R Powell Miami, FL | Family Practice | 44 | Under 11 | $59K |
| Steven A Norris Indianapolis, IN | Infectious Disease | 39 | Under 11 | $59K |
| Charles R Berman Jamaica, NY | Internal Medicine | 42 | Under 11 | $58K |
| Peter L Alpert Bronx, NY | Infectious Disease | 47 | Under 11 | $57K |
| Mark Galbraith Winchester, VA | Infectious Disease | 54 | Under 11 | $56K |
| Holly B Walker Jackson, MS | Nurse Practitioner | 30 | Under 11 | $56K |
| Ira Mintzer Cambridge, MA | Internal Medicine | 21 | Under 11 | $55K |
| Joseph J Herman Bremerton, WA | Infectious Disease | 35 | Under 11 | $55K |
| Hiram Cortes Brooklyn, NY | Infectious Disease | 17 | Under 11 | $55K |
| Greg L Strayer Long Beach, CA | Infectious Disease | 31 | Under 11 | $52K |
| Clifton C Jones Topeka, KS | Infectious Disease | 22 | Under 11 | $52K |
| Zachary Bregman New York, NY | Internal Medicine | 30 | Under 11 | $51K |
| David A Wheeler Annandale, VA | Infectious Disease | 15 | Under 11 | $49K |
| Eric V Macapinlac Sayre, PA | Anesthesiology | 30 | Under 11 | $48K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Aurobindo Pharm AUROPHARMA.NS | 15,802 | $10.9M |
| Camber Pharmace | 2,590 | $1.9M |
| Laurus Labs Lim LAURUSLABS.NS | 1,994 | $1.6M |
| Teva USA TEVA | 2,094 | $1.4M |
| Cipla USA, Inc. CIPLA.NS | 219 | $147K |
| Macleods Pharma | 429 | $87K |